<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Intraoperative parathyroid hormone assays</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Intraoperative parathyroid hormone assays</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Intraoperative parathyroid hormone assays</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carmen C Solórzano, MD, FACS, FSSO</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Denise M Carneiro-Pla, MD, FACS</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Sally E Carty, MD, FACS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Wenliang Chen, MD, PhD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 14, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H32846697"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Surgical resection of abnormal parathyroid glands is the only curative treatment for primary hyperparathyroidism [<a href="#rid1">1,2</a>]. Abnormal parathyroid glands can be removed via bilateral neck exploration or focused parathyroidectomy. </p><p>The bilateral neck exploration approach relies on visual inspection of all parathyroid glands to ensure that all abnormal ones are removed [<a href="#rid3">3,4</a>]. The focused approach, however, does not require exposure of all glands. Thus, a focused parathyroidectomy requires nonvisual confirmation that all abnormal glands have been removed in order to prevent higher failure rates. </p><p>Intraoperative parathyroid hormone (PTH) monitoring leverages the short half-life of the PTH hormone (three to five minutes) to provide the necessary assurance that a focused parathyroidectomy has been adequately performed (ie, all hypersecreting glands have been removed) before concluding the surgery [<a href="#rid5">5-8</a>]. In addition, intraoperative PTH measurements accurately predict postoperative calcium levels [<a href="#rid7">7,9-17</a>].</p><p>The use of intraoperative PTH monitoring in patients with sporadic primary hyperparathyroidism will be reviewed here. Parathyroid surgery techniques, preoperative localization of parathyroid glands, and the medical management of hyperparathyroidism are discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/15039.html" rel="external">"Parathyroid exploration for primary hyperparathyroidism"</a> and  <a class="medical medical_review" href="/d/html/2069.html" rel="external">"Preoperative localization for parathyroid surgery in patients with primary hyperparathyroidism"</a> and  <a class="medical medical_review" href="/d/html/2065.html" rel="external">"Primary hyperparathyroidism: Management"</a>.)</p><p class="headingAnchor" id="H18706042"><span class="h1">INTRAOPERATIVE PTH ASSAY</span><span class="headingEndMark"> — </span>Parathyroid hormone (PTH) assays measure circulating levels of PTH. Because the half-life of the parathyroid hormone is very short (three to five minutes), the PTH level becomes a reliable surrogate for in vivo parathyroid function. (See  <a class="medical medical_review" href="/d/html/2055.html" rel="external">"Parathyroid hormone assays and their clinical use"</a>.)</p><p>Intraoperative PTH monitoring utilizes one of the rapid immunochemiluminescence assays, which allows for repeated measurements of PTH levels while the patient is in the operating room [<a href="#rid18">18-20</a>]. The assays can be completed with a turnaround time of 8 to 20 minutes [<a href="#rid21">21</a>]. The intraoperative PTH assay should be performed in or close to the operating room to avoid delay caused by sample transport. Because of the large number of samples required to apply the intraoperative monitoring protocols, the facility is required to have a PTH assay with a fast turnaround time (&lt;15 minutes). </p><p>To perform intraoperative PTH monitoring during parathyroid surgery, blood samples are collected at predetermined time intervals by the anesthetist (via an established peripheral venous or arterial line) or the surgeon (via a needle puncture of the internal jugular vein, anterior jugular vein, or external jugular vein in the operative field). For each sample, 3 to 5 mL of whole blood is collected in an ethylenediamine tetraacetic acid (EDTA) tube. It is important to avoid hemolysis during blood collection by filling the EDTA tube completely and avoiding any shaking of the sample [<a href="#rid22">22,23</a>]. Blood samples are then sent for PTH measurement, the results of which are interpreted according to one of the intraoperative PTH monitoring protocols. </p><p class="headingAnchor" id="H32846719"><span class="h1">INTRAOPERATIVE PTH MONITORING PROTOCOLS</span><span class="headingEndMark"> — </span>Intraoperative parathyroid hormone (PTH) monitoring protocols help guide the surgical decision-making process. When properly followed, an established intraoperative PTH monitoring protocol can provide assurance that all currently hyperfunctioning parathyroid tissue has been adequately excised before the surgical procedure is concluded. </p><p>At each facility, surgeons should consistently use a protocol that is practical, specific, and reproducible under their local conditions. The goal is to cure 97 to 99 percent of patients of primary hyperparathyroidism. </p><p class="headingAnchor" id="H23422003"><span class="h2">Commonly used protocols</span><span class="headingEndMark"> — </span>The most commonly used intraoperative PTH monitoring protocols include the "&gt;50 percent PTH drop criterion" protocol and the dual criterion protocol  (<a class="graphic graphic_table graphicRef64080" href="/d/graphic/64080.html" rel="external">table 1</a>). </p><p class="headingAnchor" id="H3437358"><span class="h3">&gt;50 percent PTH drop criterion</span><span class="headingEndMark"> — </span>The &gt;50 percent PTH drop criterion protocol typically uses four intraoperative PTH samples (pre-skin-incision, pre-gland-excision or 0 minute, 5 minutes post-gland-excision, 10 minutes post-gland-excision) to construct a curve  (<a class="graphic graphic_figure graphicRef62746" href="/d/graphic/62746.html" rel="external">figure 1</a>) [<a href="#rid24">24-28</a>]. Some centers omit the pre-gland-excision and/or the 5 minute sample due to concerns of cost or proximity to the laboratory. The timing of the second (pre-gland-excision or 0 minute) sample is most critical as a collection made too early (during parathyroid gland dissection) could potentially miss the peak PTH level and lead to false negative results. This sample should be collected as the last vessel to the parathyroid gland is ligated.</p><p>The &gt;50 percent PTH drop criterion protocol sets a decrease in PTH values of &gt;50 percent from the <strong>higher </strong>level of either the pre-skin-incision level or pre-gland-excision/0 minute level as the criterion to conclude surgery. As an example, if the PTH value at 10 minutes post-gland-excision decreases &gt;50 percent from the pre-skin-incision level, the procedure can be stopped without further neck exploration or visualization of the remaining parathyroid glands. </p><p>If the PTH value does not decrease by &gt;50 percent at 10 minutes after gland excision, the surgeon can repeat the PTH level at 20 minutes. In most patients, the &gt;50 percent PTH drop criterion is met with this additional measurement [<a href="#rid25">25,29</a>]. If the criterion is still not met after 20 minutes, surgery is continued by examining the other glands. The same protocol for blood sampling is repeated for each additional gland removed or, if all glands appear abnormal, after all abnormal tissue has been removed. </p><p>In retrospective studies, the &gt;50 percent PTH drop criterion predicted postoperative eucalcemia with an accuracy of 96 to 97 percent for at least six months [<a href="#rid25">25,30,31</a>]. </p><p class="headingAnchor" id="H3437253"><span class="h3">Dual criteria protocol</span><span class="headingEndMark"> — </span>Another widely used method for PTH monitoring, the dual criteria protocol, requires a minimum of two intraoperative samples (the pre-skin-incision sample and a post-gland-excision sample)  (<a class="graphic graphic_table graphicRef64080" href="/d/graphic/64080.html" rel="external">table 1</a>) [<a href="#rid9">9,32-35</a>]. </p><p>The first sample is obtained pre-incision after induction of anesthesia. The second blood sample is collected from the same site 10 minutes after excision of the abnormal parathyroid gland. If the second PTH value decreases &gt;50 percent compared with the first sample <strong>and</strong> has returned to the normal range, the dual criteria are met and surgery is concluded [<a href="#rid11">11,14,32,36</a>]. If the second sample does not meet one or both criteria, a third sample is drawn 20 minutes after gland excision. If the third sample again fails to meet the dual criteria, further exploration is conducted until all abnormal glands are identified and removed.</p><p>Fulfillment of the dual criteria also predicts postoperative eucalcemia with an accuracy of 97 percent, according to a retrospective study of 1882 patients undergoing parathyroidectomy for primary hyperparathyroidism [<a href="#rid9">9</a>].</p><p>It is essential to mention that each intraoperative assay has its own normal range. For assays that do not publish a normal range, it is recommended that each institution determine their normal range locally.</p><p class="headingAnchor" id="H3437260"><span class="h2">Other protocols</span><span class="headingEndMark"> — </span>Other protocols for intraoperative PTH monitoring have been proposed in which the timing of PTH sampling, the required magnitude of PTH decrease, or the required final PTH value is adjusted to make the protocol more or less stringent  (<a class="graphic graphic_table graphicRef64080" href="/d/graphic/64080.html" rel="external">table 1</a>) [<a href="#rid34">34,37,38</a>]. </p><p class="headingAnchor" id="H6037975"><span class="h3">More stringent protocol</span><span class="headingEndMark"> — </span>The use of a more stringent protocol, such as requiring that the &gt;50 percent decline in PTH occur at 5 minutes rather than 10 minutes postexcision, may decrease the number of operative failures but increase the incidence of unnecessary bilateral exploration [<a href="#rid25">25</a>]. In a series of 1882 patients who underwent parathyroidectomy using the &gt;50 percent PTH drop criterion for primary hyperparathyroidism, 206 additional patients would have undergone unnecessary surgery if the criterion was required to be met at 5 rather than 10 minutes [<a href="#rid9">9</a>]. </p><p>Another more stringent protocol requires that the intraoperative PTH fall by &gt;50 percent <strong>and</strong> to a level below 40 pg/mL (which is below the upper limit of the normal range) [<a href="#rid11">11,12,39</a>]. This more stringent protocol, however, has not been evaluated prospectively but is associated with the lowest risk of persistence in retrospective studies [<a href="#rid40">40</a>]. </p><p>In a retrospective review of 896 patients who underwent bilateral exploration parathyroidectomy, using a receiver operating characteristic (ROC) analysis, the authors found that a &gt;72 percent decline in PTH intraoperatively was the best predictor of multiple gland disease [<a href="#rid41">41</a>]. </p><p class="headingAnchor" id="H6037981"><span class="h3">Less stringent protocol</span><span class="headingEndMark"> — </span>The use of a less stringent protocol minimizes unnecessary surgery but carries a higher risk of persistent hyperparathyroidism after surgery. As an example, some users of PTH monitoring accept any reduction as purportedly indicative of an adequate resection or omit altogether the use of PTH monitoring during unilateral surgery. </p><p class="headingAnchor" id="H26396565"><span class="h2">Technical and patient factors affecting all protocols</span><span class="headingEndMark"> — </span>Technical and patient factors that can cause an insufficient decline in PTH levels include decreased renal clearance in patients with chronic renal insufficiency [<a href="#rid42">42</a>], <strong>baseline</strong> sample hemodilution or hemolysis (both decrease <strong>baseline</strong> PTH value) [<a href="#rid23">23</a>], a missed PTH peak  (<a class="graphic graphic_figure graphicRef62746" href="/d/graphic/62746.html" rel="external">figure 1</a>), and laboratory errors [<a href="#rid21">21</a>]. In addition, when the baseline PTH level is drawn from an internal jugular vein ipsilateral to an abnormal gland, it can take longer for the PTH level to decrease adequately after the abnormal gland is excised [<a href="#rid43">43</a>]. (See  <a class="medical medical_review" href="/d/html/15041.html" rel="external">"Parathyroidectomy in end-stage kidney disease", section on 'Resect abnormal glands with intraoperative PTH monitoring'</a>.)</p><p>These factors can unnecessarily prolong operative and anesthesia time by mandating additional PTH testing and may also direct unnecessary excision of parathyroid glands. When these issues are suspected, a <strong>downsloping</strong> postresection PTH curve can provide some assurance that the parathyroid surgery will predict cure and in fact is often used as a key finding in deciding when to conclude the surgery [<a href="#rid44">44,45</a>]. Patients with mild hypercalcemic or normocalcemic hyperparathyroidism may have a significantly slower intraoperative PTH decline compared with hypercalcemic patients [<a href="#rid46">46,47</a>].</p><p>Technical factors such as <strong>postexcision</strong> sample dilution or hemolysis (both decrease PTH value) can lead to a falsely adequate drop in PTH, which in turn can lead to missed multiglandular disease and operative failure. </p><p class="headingAnchor" id="H7532958"><span class="h3">Renal or hereditary hyperparathyroidism</span><span class="headingEndMark"> — </span>It should be noted that most intraoperative PTH monitoring protocols are intended for patients undergoing surgery for sporadic primary hyperparathyroidism. Thus, when intraoperative PTH monitoring is used in patients with secondary or hereditary hyperparathyroidism, the usual protocols do not necessarily apply [<a href="#rid48">48</a>]. Nevertheless, retrospective studies have shown that intraoperative PTH monitoring in patients with chronic renal insufficiency and tertiary hyperparathyroidism is reliable [<a href="#rid17">17,49,50</a>]. (See  <a class="medical medical_review" href="/d/html/15040.html" rel="external">"Parathyroid surgery for inherited syndromes", section on 'Intraoperative PTH monitoring'</a> and  <a class="medical medical_review" href="/d/html/15041.html" rel="external">"Parathyroidectomy in end-stage kidney disease", section on 'Resect abnormal glands with intraoperative PTH monitoring'</a>.) </p><p>Patients with multiple endocrine neoplasia (MEN) syndrome, parathyroid carcinoma, and familial hyperparathyroidism have a higher risk of persistent or recurrent hyperparathyroidism after surgery, even when intraoperative PTH monitoring indicates that the surgery is adequate [<a href="#rid5">5-8,23,27,51-53</a>].</p><p class="headingAnchor" id="H13068013"><span class="h1">OTHER USES OF RAPID PTH ASSAYS</span><span class="headingEndMark"> — </span>Although intraoperative parathyroid hormone (PTH) assays are primarily used in focused parathyroidectomies to determine the adequacy of surgery as detailed above, such assays can also be used to lateralize hyperfunctioning parathyroid glands preoperatively, identify missing parathyroid glands, or confirm the presence of parathyroid tissue.</p><p class="headingAnchor" id="H20236638"><span class="h2">Lateralization of hyperfunctioning parathyroid gland</span><span class="headingEndMark"> — </span>Bilateral jugular venous PTH sampling can be performed preoperatively or intraoperatively to lateralize hyperfunctioning parathyroid gland(s) to one side of the neck. In patients with otherwise negative preoperative localization studies, a positive bilateral jugular venous PTH sampling (defined as ≥10 percent difference in PTH measurements) can convert a bilateral to a unilateral neck exploration. </p><p>Blood samples are taken from both internal jugular veins as distally as possible, under ultrasound guidance  (<a class="graphic graphic_figure graphicRef50992" href="/d/graphic/50992.html" rel="external">figure 2</a>). Bilateral jugular venous sampling led to a successful unilateral neck exploration in 70 to 80 percent of patients when used in conjunction with intraoperative PTH monitoring [<a href="#rid54">54,55</a>]. (See <a class="local">'Intraoperative PTH monitoring protocols'</a> above.)</p><p class="headingAnchor" id="H6038184"><span class="h2">Missing glands</span><span class="headingEndMark"> — </span>Bilateral jugular venous sampling for PTH levels can also be performed at the time of neck exploration to localize a missing gland, especially during a difficult exploration. A unilateral elevation of PTH leads the surgeon to explore the ipsilateral side of the neck for a missing hyperfunctioning gland. Similar readings on both sides of the neck in the context of a missing gland may suggest the presence of hyperfunctioning parathyroid disease outside the neck (eg, in the mediastinum). (See  <a class="medical medical_review" href="/d/html/15039.html" rel="external">"Parathyroid exploration for primary hyperparathyroidism", section on 'Missing gland'</a>.)</p><p class="headingAnchor" id="H32846756"><span class="h2">Identifying parathyroid tissue</span><span class="headingEndMark"> — </span>Pre- or intraoperative fine needle aspiration of parathyroid tissue for PTH measurement can differentiate parathyroid tissue from other tissues with a high specificity [<a href="#rid56">56,57</a>]. A 25 gauge needle attached to a syringe is used to collect the tissue sample. The aspirated content is diluted with 1 mL of <a class="drug drug_general" data-topicid="9929" href="/d/drug information/9929.html" rel="external">saline</a> solution and centrifuged, and the supernatant is used for PTH measurement with a rapid PTH assay [<a href="#rid58">58</a>]. This technique allows quick tissue identification of parathyroid tissue without frozen section, which can help distinguish an intrathyroidal parathyroid gland from a thyroid nodule or an enlarged lymph node. (See  <a class="medical medical_review" href="/d/html/15039.html" rel="external">"Parathyroid exploration for primary hyperparathyroidism", section on 'First gland'</a>.)</p><p class="headingAnchor" id="H738252"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>The outcomes of patients who undergo focused parathyroidectomy guided by intraoperative parathyroid hormone (PTH) monitoring support its use by the majority of endocrine surgeons.</p><p>Because imaging commonly misses multiple gland disease, most high-volume endocrine surgeons with complex practices use intraoperative PTH to guide not only focused parathyroidectomy but bilateral neck explorations as well [<a href="#rid59">59,60</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>For patients with sporadic primary hyperparathyroidism, parathyroid exploration guided by intraoperative PTH monitoring is successful in &gt;97 percent of cases, with less extensive surgical dissection, shorter operative times, and smaller incisions than bilateral neck exploration [<a href="#rid5">5-8,32,36</a>]. </p><p></p><p class="bulletIndent1">Although some specialists can perform a bilateral neck exploration with small incisions and as an outpatient procedure, it often leads to a more extensive dissection and excision of additional "enlarged" glands that are assumed to be hyperfunctioning [<a href="#rid34">34,61-67</a>]. However, gland size or weight does not always correlate with parathyroid function [<a href="#rid68">68</a>]. Compared with bilateral neck exploration, a focused parathyroidectomy guided by intraoperative PTH monitoring is not clearly associated with a higher recurrence rate [<a href="#rid69">69,70</a>]. However, the follow-up in these studies is limited [<a href="#rid7">7,11,12,31,71-73</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Focused operations using intraoperative PTH monitoring are often outpatient procedures. Compared with bilateral neck explorations that often require admission [<a href="#rid59">59</a>], focused operations can lead to a 50 percent decrease in hospital costs and patient charges, despite an increase in laboratory costs [<a href="#rid66">66,74</a>]. However, the costs are not different if bilateral neck exploration can be performed as an outpatient procedure as well [<a href="#rid75">75</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For patients with equivocal or negative preoperative localization studies [<a href="#rid76">76</a>] and those requiring reoperation [<a href="#rid26">26,77,78</a>], intraoperative PTH monitoring improves the operative success rate, allowing successful unilateral neck exploration in more than 80 percent of such patients.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The incidence of multiglandular disease in patients with sporadic hyperparathyroidism ranges from 5 to 30 percent [<a href="#rid79">79,80</a>]. The use of the &gt;50 percent PTH drop criterion results in multigland resections in 3 to 10 percent of patients with an operative success rate of 97 to 98 percent [<a href="#rid30">30,38,69,81-84</a>]. The rates of multiple gland resection are higher when the dual criteria are used or when a bilateral neck exploration is performed without substantial increase in success rates [<a href="#rid18">18,31,33,63,75,85-87</a>]. (See <a class="local">'Commonly used protocols'</a> above.)</p><p></p><p class="headingAnchor" id="H939571637"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/114502.html" rel="external">"Society guideline links: Parathyroid surgery"</a>.) </p><p class="headingAnchor" id="H32846777"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Goals</strong> – Intraoperative parathyroid hormone (PTH) monitoring allows a more focused, less invasive approach to parathyroidectomy and signals the need for more exploration when PTH drop criterion is not met. Monitoring changes in PTH levels during surgery for sporadic primary hyperparathyroidism provides a useful tool to indicate when all hyperfunctioning parathyroid tissue has been adequately excised and accurately predicts postoperative normal or low calcium levels. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rationale</strong> – Intraoperative PTH monitoring takes advantage of the short plasma half-life (three to five minutes) of PTH by using a rapid assay technique that allows measurements while the patient is still in the operating room. (See <a class="local">'Intraoperative PTH assay'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Common protocols of intraoperative PTH monitoring</strong> – At each facility, surgeons should consistently use a protocol that is practical, specific, and reproducible under their local conditions, with the goal of curing 97 to 99 percent of patients of hyperparathyroidism. Two protocols are commonly used. (See <a class="local">'Intraoperative PTH monitoring protocols'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The &gt;50 percent PTH drop criterion typically uses four intraoperative PTH samples (pre-skin-incision, pre-gland-excision or 0 minute, 5 minutes post-gland-excision, 10 minutes post-gland-excision). Surgery is concluded when there is a decrease in PTH values of &gt;50 percent from the <strong>higher </strong>level of either the pre-skin-incision level or pre-gland-excision level.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The dual criteria require a minimum of two intraoperative samples (a pre-skin-incision level and another one at 10 minutes post-gland-excision). Surgery is concluded when the second PTH level decreases &gt;50 percent compared with the first sample <strong>and</strong> has returned to the normal range.</p><p></p><p class="bulletIndent1">The &gt;50 percent PTH drop and dual criteria are intended for patients who have sporadic, primary hyperparathyroidism. They do <strong>not</strong> necessarily apply to patients with renal or hereditary hyperparathyroidism.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other uses of rapid PTH assays</strong> – Rapid PTH assays can also be used to lateralize hyperfunctioning parathyroid glands pre- and intraoperatively, identify missing parathyroid glands, or confirm the presence of parathyroid tissue. (See <a class="local">'Other uses of rapid PTH assays'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Outcomes of intraoperative PTH monitoring</strong> – Intraoperative PTH monitoring allows some patients to undergo a focused parathyroidectomy with less time, less dissection, possibly lower cost and smaller incision, and equal success rate, compared with a bilateral neck exploration, but is also used for bilateral neck explorations by high-volume endocrine surgeons with complex practices. (See <a class="local">'Outcomes'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Fraker DL, Harsono H, Lewis R. Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. long-term results. World J Surg 2009; 33:2256.</a></li><li><a class="nounderline abstract_t">Wilhelm SM, Wang TS, Ruan DT, et al. The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism. JAMA Surg 2016; 151:959.</a></li><li><a class="nounderline abstract_t">Norman J, Lopez J, Politz D. Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations. J Am Coll Surg 2012; 214:260.</a></li><li><a class="nounderline abstract_t">Chen H, Wang TS, Yen TW, et al. Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume. Ann Surg 2010; 252:691.</a></li><li><a class="nounderline abstract_t">Irvin GL 3rd, Dembrow VD, Prudhomme DL. Operative monitoring of parathyroid gland hyperfunction. Am J Surg 1991; 162:299.</a></li><li><a class="nounderline abstract_t">Chapuis Y, Icard P, Fulla Y, et al. [Excision under local anesthesia of parathyroid adenomas. Criteria of selection and control of effectiveness. 35 cases]. Presse Med 1991; 20:2090.</a></li><li><a class="nounderline abstract_t">Schneider DF, Mazeh H, Sippel RS, Chen H. Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases. Surgery 2012; 152:1008.</a></li><li><a class="nounderline abstract_t">Greene AB, Butler RS, McIntyre S, et al. National trends in parathyroid surgery from 1998 to 2008: a decade of change. J Am Coll Surg 2009; 209:332.</a></li><li><a class="nounderline abstract_t">Richards ML, Thompson GB, Farley DR, Grant CS. An optimal algorithm for intraoperative parathyroid hormone monitoring. Arch Surg 2011; 146:280.</a></li><li><a class="nounderline abstract_t">Udelsman R, Lin Z, Donovan P. The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg 2011; 253:585.</a></li><li><a class="nounderline abstract_t">Wharry LI, Yip L, Armstrong MJ, et al. The final intraoperative parathyroid hormone level: how low should it go? World J Surg 2014; 38:558.</a></li><li><a class="nounderline abstract_t">Rajaei MH, Bentz AM, Schneider DF, et al. Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) Over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism. Ann Surg Oncol 2015; 22:454.</a></li><li><a class="nounderline abstract_t">Lee S, Ryu H, Morris LF, et al. Operative failure in minimally invasive parathyroidectomy utilizing an intraoperative parathyroid hormone assay. Ann Surg Oncol 2014; 21:1878.</a></li><li><a class="nounderline abstract_t">Wachtel H, Cerullo I, Bartlett EK, et al. What Can We Learn from Intraoperative Parathyroid Hormone Levels that Do Not Drop Appropriately? Ann Surg Oncol 2015; 22:1781.</a></li><li><a class="nounderline abstract_t">Hughes DT, Miller BS, Park PB, et al. Factors in conversion from minimally invasive parathyroidectomy to bilateral parathyroid exploration for primary hyperparathyroidism. Surgery 2013; 154:1428.</a></li><li><a class="nounderline abstract_t">Elfenbein DM, Weber S, Schneider DF, et al. CaPTHUS scoring model in primary hyperparathyroidism: can it eliminate the need for ioPTH testing? Ann Surg Oncol 2015; 22:1191.</a></li><li><a class="nounderline abstract_t">Marcadis AR, Teo R, Ouyang W, et al. Successful parathyroidectomy guided by intraoperative parathyroid hormone monitoring for primary hyperparathyroidism is preserved in mild and moderate renal insufficiency. Surgery 2018; 163:633.</a></li><li><a class="nounderline abstract_t">Carneiro DM, Irvin GL 3rd. Late parathyroid function after successful parathyroidectomy guided by intraoperative hormone assay (QPTH) compared with the standard bilateral neck exploration. Surgery 2000; 128:925.</a></li><li><a class="nounderline abstract_t">Sokoll LJ, Drew H, Udelsman R. Intraoperative parathyroid hormone analysis: A study of 200 consecutive cases. Clin Chem 2000; 46:1662.</a></li><li><a class="nounderline abstract_t">Delbridge LW, Dolan SJ, Hop TT, et al. Minimally invasive parathyroidectomy: 50 consecutive cases. Med J Aust 2000; 172:418.</a></li><li><a class="nounderline abstract_t">Carneiro-Pla D. Contemporary and practical uses of intraoperative parathyroid hormone monitoring. Endocr Pract 2011; 17 Suppl 1:44.</a></li><li><a class="nounderline abstract_t">Lippi G, Blanckaert N, Bonini P, et al. Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories. Clin Chem Lab Med 2008; 46:764.</a></li><li><a class="nounderline abstract_t">Moalem J, Ruan DT, Farkas RL, et al. Prospective evaluation of the rate and impact of hemolysis on intraoperative parathyroid hormone (IOPTH) assay results. Ann Surg Oncol 2010; 17:2963.</a></li><li><a class="nounderline abstract_t">Irvin GL 3rd, Prudhomme DL, Deriso GT, et al. A new approach to parathyroidectomy. Ann Surg 1994; 219:574.</a></li><li><a class="nounderline abstract_t">Carneiro DM, Solorzano CC, Nader MC, et al. Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate? Surgery 2003; 134:973.</a></li><li><a class="nounderline abstract_t">Irvin GL 3rd, Solorzano CC, Carneiro DM. Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome. World J Surg 2004; 28:1287.</a></li><li><a class="nounderline abstract_t">Solórzano CC, Carneiro-Pla DM, Lew JI, et al. Intra-operative parathyroid hormone monitoring in patients with parathyroid cancer. Ann Surg Oncol 2007; 14:3216.</a></li><li><a class="nounderline abstract_t">Irvin GL 3rd, Deriso GT 3rd. A new, practical intraoperative parathyroid hormone assay. Am J Surg 1994; 168:466.</a></li><li><a class="nounderline abstract_t">Di Stasio E, Carrozza C, Pio Lombardi C, et al. Parathyroidectomy monitored by intra-operative PTH: the relevance of the 20 min end-point. Clin Biochem 2007; 40:595.</a></li><li><a class="nounderline abstract_t">Johnson LR, Doherty G, Lairmore T, et al. Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy. Clin Chem 2001; 47:919.</a></li><li><a class="nounderline abstract_t">Carneiro DM, Solorzano CC, Irvin GL 3rd. Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg 2004; 199:849.</a></li><li><a class="nounderline abstract_t">Carty SE, Worsey J, Virji MA, et al. Concise parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay. Surgery 1997; 122:1107.</a></li><li><a class="nounderline abstract_t">Burkey SH, Van Heerden JA, Farley DR, et al. Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyroidism? World J Surg 2002; 26:914.</a></li><li><a class="nounderline abstract_t">Chiu B, Sturgeon C, Angelos P. Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients. Arch Surg 2006; 141:483.</a></li><li><a class="nounderline abstract_t">Yang GP, Levine S, Weigel RJ. A spike in parathyroid hormone during neck exploration may cause a false-negative intraoperative assay result. Arch Surg 2001; 136:945.</a></li><li><a class="nounderline abstract_t">Carty SE, Roberts MM, Virji MA, et al. Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism. Surgery 2002; 132:1086.</a></li><li><a class="nounderline abstract_t">Irvin GL 3rd, Dembrow VD, Prudhomme DL. Clinical usefulness of an intraoperative "quick parathyroid hormone" assay. Surgery 1993; 114:1019.</a></li><li><a class="nounderline abstract_t">Garner SC, Leight GS Jr. Initial experience with intraoperative PTH determinations in the surgical management of 130 consecutive cases of primary hyperparathyroidism. Surgery 1999; 126:1132.</a></li><li><a class="nounderline abstract_t">Heller KS, Blumberg SN. Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy. Arch Otolaryngol Head Neck Surg 2009; 135:1103.</a></li><li><a class="nounderline abstract_t">Claflin J, Dhir A, Espinosa NM, et al. Intraoperative parathyroid hormone levels ≤40 pg/mL are associated with the lowest persistence rates after parathyroidectomy for primary hyperparathyroidism. Surgery 2019; 166:50.</a></li><li><a class="nounderline abstract_t">Foley CS, Moore EC, Milas M, et al. RECEIVER OPERATING CHARACTERISTIC ANALYSIS OF INTRAOPERATIVE PARATHYROID HORMONE MONITORING TO DETERMINE OPTIMUM SENSITIVITY AND SPECIFICITY: ANALYSIS OF 896 CASES. Endocr Pract 2019; 25:1117.</a></li><li><a class="nounderline abstract_t">Sohn JA, Oltmann SC, Schneider DF, et al. Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate? Am J Surg 2015; 209:483.</a></li><li><a class="nounderline abstract_t">Beyer TD, Chen E, Ata A, et al. A prospective evaluation of the effect of sample collection site on intraoperative parathormone monitoring during parathyroidectomy. Surgery 2008; 144:504.</a></li><li><a class="nounderline abstract_t">Wang TS, Pasieka JL, Carty SE. Techniques of parathyroid exploration at North American endocrine surgery fellowship programs: what the next generation is being taught. Am J Surg 2014; 207:527.</a></li><li><a class="nounderline abstract_t">Carr AA, Yen TW, Wilson SD, et al. Using parathyroid hormone spikes during parathyroidectomy to guide intraoperative decision-making. J Surg Res 2017; 209:162.</a></li><li><a class="nounderline abstract_t">Graves CE, McManus CM, Chabot JA, et al. Biochemical Profile Affects IOPTH Kinetics and Cure Rate in Primary Hyperparathyroidism. World J Surg 2020; 44:488.</a></li><li><a class="nounderline abstract_t">Shawky MS, Sakr MF, Nabawi AS, et al. Influence of common clinical variables on intraoperative parathyroid hormone monitoring during surgery for primary hyperparathyroidism. J Endocrinol Invest 2020; 43:1205.</a></li><li><a class="nounderline abstract_t">Ermer JP, Kelz RR, Fraker DL, Wachtel H. Intraoperative Parathyroid Hormone Monitoring in Parathyroidectomy for Tertiary Hyperparathyroidism. J Surg Res 2019; 244:77.</a></li><li><a class="nounderline abstract_t">Sunkara B, Cohen MS, Miller BS, et al. Influence of concurrent chronic kidney disease on intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism. Surgery 2018; 163:42.</a></li><li><a class="nounderline abstract_t">Pitt SC, Panneerselvan R, Chen H, Sippel RS. Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring. World J Surg 2010; 34:1343.</a></li><li><a class="nounderline abstract_t">Nilubol N, Weisbrod AB, Weinstein LS, et al. Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy. World J Surg 2013; 37:1966.</a></li><li><a class="nounderline abstract_t">Pieterman CR, van Hulsteijn LT, den Heijer M, et al. Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg 2012; 255:1171.</a></li><li><a class="nounderline abstract_t">Carneiro DM, Irvin GL 3rd, Inabnet WB. Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism. Surgery 2002; 132:1050.</a></li><li><a class="nounderline abstract_t">Ito F, Sippel R, Lederman J, Chen H. The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 2007; 245:959.</a></li><li><a class="nounderline abstract_t">Carneiro-Pla D. Effectiveness of "office"-based, ultrasound-guided differential jugular venous sampling (DJVS) of parathormone in patients with primary hyperparathyroidism. Surgery 2009; 146:1014.</a></li><li><a class="nounderline abstract_t">Doppman JL, Krudy AG, Marx SJ, et al. Aspiration of enlarged parathyroid glands for parathyroid hormone assay. Radiology 1983; 148:31.</a></li><li><a class="nounderline abstract_t">Horányi J, Duffek L, Szlávik R, et al. Intraoperative determination of PTH concentrations in fine needle tissue aspirates to identify parathyroid tissue during parathyroidectomy. World J Surg 2010; 34:538.</a></li><li><a class="nounderline abstract_t">Patel SG, Yip L, Wang TS, et al. Intraoperative parathyroid hormone aspiration: Implementation and technique. VideoEndocrinology 2016; 3.</a></li><li><a class="nounderline abstract_t">Kiernan CM, Wang T, Perrier ND, et al. Bilateral Neck Exploration for Sporadic Primary Hyperparathyroidism: Use Patterns in 5,597 Patients Undergoing Parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program. J Am Coll Surg 2019; 228:652.</a></li><li><a class="nounderline abstract_t">Ishii H, Stechman MJ, Watkinson JC, et al. A Review of Parathyroid Surgery for Primary Hyperparathyroidism from the United Kingdom Registry of Endocrine and Thyroid Surgery (UKRETS). World J Surg 2021; 45:782.</a></li><li><a class="nounderline abstract_t">Miura D, Wada N, Arici C, et al. Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy? World J Surg 2002; 26:926.</a></li><li><a class="nounderline abstract_t">Perrier ND, Ituarte PH, Morita E, et al. Parathyroid surgery: separating promise from reality. J Clin Endocrinol Metab 2002; 87:1024.</a></li><li><a class="nounderline abstract_t">Gordon LL, Snyder WH 3rd, Wians F Jr, et al. The validity of quick intraoperative parathyroid hormone assay: an evaluation in seventy-two patients based on gross morphologic criteria. Surgery 1999; 126:1030.</a></li><li><a class="nounderline abstract_t">Weber CJ, Ritchie JC. Retrospective analysis of sequential changes in serum intact parathyroid hormone levels during conventional parathyroid exploration. Surgery 1999; 126:1139.</a></li><li><a class="nounderline abstract_t">Riss P, Kaczirek K, Heinz G, et al. A "defined baseline" in PTH monitoring increases surgical success in patients with multiple gland disease. Surgery 2007; 142:398.</a></li><li><a class="nounderline abstract_t">De Pasquale L, Gobatti D, Ravini ML, et al. Intra-operative testing for parathyroid hormone: the Central Laboratory option. J Endocrinol Invest 2008; 31:62.</a></li><li><a class="nounderline abstract_t">Siperstein A, Berber E, Barbosa GF, et al. Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 2008; 248:420.</a></li><li><a class="nounderline abstract_t">Liechty RD, Teter A, Suba EJ. The tiny parathyroid adenoma. Surgery 1986; 100:1048.</a></li><li><a class="nounderline abstract_t">Genc H, Morita E, Perrier ND, et al. Differing histologic findings after bilateral and focused parathyroidectomy. J Am Coll Surg 2003; 196:535.</a></li><li><a class="nounderline abstract_t">Miccoli P, Berti P, Materazzi G, et al. Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial. Surg Endosc 2008; 22:398.</a></li><li><a class="nounderline abstract_t">Lew JI, Irvin GL 3rd. Focused parathyroidectomy guided by intra-operative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome. Surgery 2009; 146:1021.</a></li><li><a class="nounderline abstract_t">Norlén O, Wang KC, Tay YK, et al. No need to abandon focused parathyroidectomy: a multicenter study of long-term outcome after surgery for primary hyperparathyroidism. Ann Surg 2015; 261:991.</a></li><li><a class="nounderline abstract_t">Ishii H, Mihai R, Watkinson JC, Kim DS. Systematic review of cure and recurrence rates following minimally invasive parathyroidectomy. BJS Open 2018; 2:364.</a></li><li><a class="nounderline abstract_t">Chen H, Sokoll LJ, Udelsman R. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery 1999; 126:1016.</a></li><li><a class="nounderline abstract_t">Kiernan CM, Schlegel C, Isom C, et al. Ambulatory bilateral neck exploration for primary hyperparathyroidism: is it safe? Am J Surg 2016; 212:722.</a></li><li><a class="nounderline abstract_t">Thier M, Nordenström E, Bergenfelz A, Westerdahl J. Surgery for patients with primary hyperparathyroidism and negative sestamibi scintigraphy--a feasibility study. Langenbecks Arch Surg 2009; 394:881.</a></li><li><a class="nounderline abstract_t">Irvin GL 3rd, Molinari AS, Figueroa C, Carneiro DM. Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay. Ann Surg 1999; 229:874.</a></li><li><a class="nounderline abstract_t">Irvin GL 3rd, Carneiro DM, Solorzano CC. Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 2004; 239:704.</a></li><li><a class="nounderline abstract_t">Gill MT, Dean M, Karr J, et al. Intraoperative parathyroid hormone assay: a necessary tool for multiglandular disease. Otolaryngol Head Neck Surg 2011; 144:691.</a></li><li><a class="nounderline abstract_t">Lew JI, Solorzano CC, Montano RE, et al. Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies. Surgery 2008; 144:299.</a></li><li><a class="nounderline abstract_t">Miccoli P, Berti P, Materazzi G, et al. Results of video-assisted parathyroidectomy: single institution's six-year experience. World J Surg 2004; 28:1216.</a></li><li><a class="nounderline abstract_t">Vignali E, Picone A, Materazzi G, et al. A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases. Eur J Endocrinol 2002; 146:783.</a></li><li><a class="nounderline abstract_t">Inabnet WB 3rd, Dakin GF, Haber RS, et al. Targeted parathyroidectomy in the era of intraoperative parathormone monitoring. World J Surg 2002; 26:921.</a></li><li><a class="nounderline abstract_t">Thanasoulis L, Bingener J, Sirinek K, Richards M. A successful application of the intraoperative parathyroid hormone assay in tertiary hyperparathyroidism. Am Surg 2007; 73:281.</a></li><li><a class="nounderline abstract_t">Carneiro-Pla DM, Solorzano CC, Lew JI, Irvin GL 3rd. Long-term outcome of patients with intraoperative parathyroid level remaining above the normal range during parathyroidectomy. Surgery 2008; 144:989.</a></li><li><a class="nounderline abstract_t">Tezelman S, Shen W, Shaver JK, et al. Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy. Ann Surg 1993; 218:300.</a></li><li><a class="nounderline abstract_t">Proye CA, Carnaille B, Bizard JP, et al. Multiglandular disease in seemingly sporadic primary hyperparathyroidism revisited: where are we in the early 1990s? A plea against unilateral parathyroid exploration. Surgery 1992; 112:1118.</a></li></ol></div><div id="topicVersionRevision">Topic 15031 Version 17.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19763685" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Minimally invasive parathyroidectomy: benefits and requirements of localization, diagnosis, and intraoperative PTH monitoring. long-term results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27532368" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The American Association of Endocrine Surgeons Guidelines for Definitive Management of Primary Hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22265807" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Abandoning unilateral parathyroidectomy: why we reversed our position after 15,000 parathyroid operations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20881776" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Operative failures after parathyroidectomy for hyperparathyroidism: the influence of surgical volume.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1683177" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Operative monitoring of parathyroid gland hyperfunction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1662378" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : [Excision under local anesthesia of parathyroid adenomas. Criteria of selection and control of effectiveness. 35 cases].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23063313" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Is minimally invasive parathyroidectomy associated with greater recurrence compared to bilateral exploration? Analysis of more than 1,000 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19717037" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : National trends in parathyroid surgery from 1998 to 2008: a decade of change.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21422358" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : An optimal algorithm for intraoperative parathyroid hormone monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21183844" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24253106" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : The final intraoperative parathyroid hormone level: how low should it go?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25192677" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Justified follow-up: a final intraoperative parathyroid hormone (ioPTH) Over 40 pg/mL is associated with an increased risk of persistence and recurrence in primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24452409" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Operative failure in minimally invasive parathyroidectomy utilizing an intraoperative parathyroid hormone assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25354574" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : What Can We Learn from Intraoperative Parathyroid Hormone Levels that Do Not Drop Appropriately?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24008086" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Factors in conversion from minimally invasive parathyroidectomy to bilateral parathyroid exploration for primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25212837" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : CaPTHUS scoring model in primary hyperparathyroidism: can it eliminate the need for ioPTH testing?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29273178" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Successful parathyroidectomy guided by intraoperative parathyroid hormone monitoring for primary hyperparathyroidism is preserved in mild and moderate renal insufficiency.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11114625" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Late parathyroid function after successful parathyroidectomy guided by intraoperative hormone assay (QPTH) compared with the standard bilateral neck exploration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11017947" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Intraoperative parathyroid hormone analysis: A study of 200 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10870533" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Minimally invasive parathyroidectomy: 50 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21247846" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Contemporary and practical uses of intraoperative parathyroid hormone monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18601596" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Haemolysis: an overview of the leading cause of unsuitable specimens in clinical laboratories.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20552403" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Prospective evaluation of the rate and impact of hemolysis on intraoperative parathyroid hormone (IOPTH) assay results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8185406" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : A new approach to parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14668730" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Comparison of intraoperative iPTH assay (QPTH) criteria in guiding parathyroidectomy: which criterion is the most accurate?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15517474" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Quick intraoperative parathyroid hormone assay: surgical adjunct to allow limited parathyroidectomy, improve success rate, and predict outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17805932" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Intra-operative parathyroid hormone monitoring in patients with parathyroid cancer.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7977975" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : A new, practical intraoperative parathyroid hormone assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17349989" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Parathyroidectomy monitored by intra-operative PTH: the relevance of the 20 min end-point.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11325897" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Evaluation of the performance and clinical impact of a rapid intraoperative parathyroid hormone assay in conjunction with preoperative imaging and concise parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15555964" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9426426" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Concise parathyroidectomy: the impact of preoperative SPECT 99mTc sestamibi scanning and intraoperative quick parathormone assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12016483" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Will directed parathyroidectomy utilizing the gamma probe or intraoperative parathyroid hormone assay replace bilateral cervical exploration as the preferred operation for primary hyperparathyroidism?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16702520" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Which intraoperative parathyroid hormone assay criterion best predicts operative success? A study of 352 consecutive patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11485536" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A spike in parathyroid hormone during neck exploration may cause a false-negative intraoperative assay result.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12490859" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8256205" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Clinical usefulness of an intraoperative "quick parathyroid hormone" assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10598198" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Initial experience with intraoperative PTH determinations in the surgical management of 130 consecutive cases of primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19917922" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30975497" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Intraoperative parathyroid hormone levels≤40 pg/mL are associated with the lowest persistence rates after parathyroidectomy for primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31414903" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : RECEIVER OPERATING CHARACTERISTIC ANALYSIS OF INTRAOPERATIVE PARATHYROID HORMONE MONITORING TO DETERMINE OPTIMUM SENSITIVITY AND SPECIFICITY: ANALYSIS OF 896 CASES.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25556028" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Is intraoperative parathyroid hormone testing in patients with renal insufficiency undergoing parathyroidectomy for primary hyperparathyroidism accurate?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18847632" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : A prospective evaluation of the effect of sample collection site on intraoperative parathormone monitoring during parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24495320" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Techniques of parathyroid exploration at North American endocrine surgery fellowship programs: what the next generation is being taught.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28032553" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Using parathyroid hormone spikes during parathyroidectomy to guide intraoperative decision-making.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31511943" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Biochemical Profile Affects IOPTH Kinetics and Cure Rate in Primary Hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32124267" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Influence of common clinical variables on intraoperative parathyroid hormone monitoring during surgery for primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31279997" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Intraoperative Parathyroid Hormone Monitoring in Parathyroidectomy for Tertiary Hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29128188" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Influence of concurrent chronic kidney disease on intraoperative parathyroid hormone monitoring during parathyroidectomy for primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20386902" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Secondary and tertiary hyperparathyroidism: the utility of ioPTH monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23722465" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Utility of intraoperative parathyroid hormone monitoring in patients with multiple endocrine neoplasia type 1-associated primary hyperparathyroidism undergoing initial parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22470073" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12490854" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Limited versus radical parathyroidectomy in familial isolated primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17522522" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19958928" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Effectiveness of "office"-based, ultrasound-guided differential jugular venous sampling (DJVS) of parathormone in patients with primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6856859" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Aspiration of enlarged parathyroid glands for parathyroid hormone assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20052470" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Intraoperative determination of PTH concentrations in fine needle tissue aspirates to identify parathyroid tissue during parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Intraoperative parathyroid hormone aspiration: Implementation and technique</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30677525" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Bilateral Neck Exploration for Sporadic Primary Hyperparathyroidism: Use Patterns in 5,597 Patients Undergoing Parathyroidectomy in the Collaborative Endocrine Surgery Quality Improvement Program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33263777" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : A Review of Parathyroid Surgery for Primary Hyperparathyroidism from the United Kingdom Registry of Endocrine and Thyroid Surgery (UKRETS).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11965444" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Does intraoperative quick parathyroid hormone assay improve the results of parathyroidectomy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11889156" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Parathyroid surgery: separating promise from reality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10598184" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : The validity of quick intraoperative parathyroid hormone assay: an evaluation in seventy-two patients based on gross morphologic criteria.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10598199" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Retrospective analysis of sequential changes in serum intact parathyroid hormone levels during conventional parathyroid exploration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17723893" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : A "defined baseline" in PTH monitoring increases surgical success in patients with multiple gland disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18296907" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Intra-operative testing for parathyroid hormone: the Central Laboratory option.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18791362" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3787460" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : The tiny parathyroid adenoma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12691927" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Differing histologic findings after bilateral and focused parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17522920" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Endoscopic bilateral neck exploration versus quick intraoperative parathormone assay (qPTHa) during endoscopic parathyroidectomy: A prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19879612" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Focused parathyroidectomy guided by intra-operative parathormone monitoring does not miss multiglandular disease in patients with sporadic primary hyperparathyroidism: a 10-year outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25565223" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : No need to abandon focused parathyroidectomy: a multicenter study of long-term outcome after surgery for primary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30511037" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Systematic review of cure and recurrence rates following minimally invasive parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10598182" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27659156" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Ambulatory bilateral neck exploration for primary hyperparathyroidism: is it safe?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19547996" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Surgery for patients with primary hyperparathyroidism and negative sestamibi scintigraphy--a feasibility study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10363902" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Improved success rate in reoperative parathyroidectomy with intraoperative PTH assay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15082975" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Progress in the operative management of sporadic primary hyperparathyroidism over 34 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21493339" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Intraoperative parathyroid hormone assay: a necessary tool for multiglandular disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18656639" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Role of intraoperative parathormone monitoring during parathyroidectomy in patients with discordant localization studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15517483" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Results of video-assisted parathyroidectomy: single institution's six-year experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12039698" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : A quick intraoperative parathyroid hormone assay in the surgical management of patients with primary hyperparathyroidism: a study of 206 consecutive cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12016471" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Targeted parathyroidectomy in the era of intraoperative parathormone monitoring.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17375788" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : A successful application of the intraoperative parathyroid hormone assay in tertiary hyperparathyroidism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19041008" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Long-term outcome of patients with intraoperative parathyroid level remaining above the normal range during parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8103983" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Double parathyroid adenomas. Clinical and biochemical characteristics before and after parathyroidectomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1280860" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Multiglandular disease in seemingly sporadic primary hyperparathyroidism revisited: where are we in the early 1990s? A plea against unilateral parathyroid exploration.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
